Dr. Sumangala F Huded, MD Internal Medicine - Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 78 Marlborough St, Portland, CT 06480 Phone: 860-342-4800 Fax: 860-342-3298 |
News Archive
Halo Therapeutics, LLC, a clinical-stage biopharmaceutical company developing novel therapeutics for rare fibrotic diseases, announced today that the TREAT-NMD Advisory Committee on Therapeutics (TACT) has reviewed HT-100, Halo's drug candidate for Duchenne muscular dystrophy (DMD), and believes the compound has potential based on the proposed mechanism.
The U.S. Food and Drug Administration today approved the first medical device that uses radiofrequency energy to treat severe and persistent asthma in certain adults.
Experts at the World Health Summit highlighted health concerns related to the growth of megacities, "roughly defined as cities with a population of more than 10 million," Agence France-Presse reports.
St. Jude Children's Research Hospital scientists have identified a protein that certain high-risk acute lymphoblastic leukemia (ALL) cells need to survive and have used that knowledge to fashion a more effective method of killing tumor cells. The findings appear in the August 29 edition of the journal Blood.
New research from North Carolina State University will help medical examiners and others identify human remains of those killed during the recent earthquake in Chile, as well as the bodies of the "disappeared" who were killed during the Pinochet administration.
› Verified 2 days ago